In this next installment of Breast Cancer Breakthroughs, we share some of the biggest research findings and highlights from the 2025 ASCO meeting.| Susan G. Komen®
Immunotherapy is becoming a more prominent option for people with breast cancer, especially those with certain subtypes of breast cancer.| Susan G. Komen®
In this episode of Breast Cancer Breakthroughs, we speak with Komen grantees Dr. Tarah Ballinger, medical oncologist at Indiana University School of Medicine, and Dr. Pedram Razavi, medical oncologist at Memorial Sloan Kettering Cancer Center, about the biggest highlights from the 2024 ASCO Annual Meeting and what they could mean for patients.| Susan G. Komen®